2017 International Congress Archives - Page 53 of 155

F-18-DOPA-PET predicts impulsive behavior under dopaminergic therapy in Parkinson patients

J. Hammes, M. Tittgemeyer, C. Eggers, A. Drzezga, T. van Eimeren (Cologne, Germany)
Factors associated with health related Quality of Life (HRQOL) in Korean Parkinson patients

J.H. Kang, S. Jang, J.-s. Kim, S.J. Chung, J.S. Baik, Y.J. Kim, H.-I. Ma (Jeju, Republic of Korea)
Factors associated with occurrence of motor complications among Parkinson’s disease patients with levodopa treatment in Estonia

L. Kadastik-Eerme, N. Taba, T. Asser, P. Taba (Tartu, Estonia)
Factors associated with perceived walking difficulties in people with Parkinson’s disease

M. Kader, S. Ullén, S. Iwarsson, P. Odin, M. Nilsson (Lund, Sweden)
Factors determining the motor outcome of STN DBS in PD patients: Evidence for Dual Actions

C. Lee, E.J. Choi, S.-C. Park, J.K. Lee (Seoul, Republic of Korea)
Factors Influencing Completion of Predictive Testing for Huntington’s Disease (HD)

M. Patel, V. Sung (Birmingham, AL, USA)
Factors that contribute to the greatest levels of caregiver strain in Parkinson’s

A. Hand, L. Oates, W. Gray, R. Walker (North Shields, United Kingdom)
Falls characteristics of male and female patients with Parkinson’s disease (PD)

G. Alg, A. Chatterjee, F. Zahir (Reading, United Kingdom)
Falls in Parkinson’s disease are related to delayed recovery time after unexpected external perturbations

V. Beretta, F. Barbieri, D. Orcioli-Silva, P. Santos, M. Pereira, R. Vitório, L. Gobbi (Rio Claro, Brazil)
Familial Creutzfeldt-Jakob Disease with an E200K Mutation in Peru: A Case Report

H. Sarapura-Castro, C. Cosentino, L. Torres-Ramirez, P. Parchi, A. Vishnevetsky, M. Inca-Martinez, E. Figueroa-Ildefonso, P. Mazzetti, M. Cornejo-Olivas (Lima, Peru)
Familial idiopathic basal ganglia calcification with novel SLC20A2 gene variant

B. Barton (Chicago, IL, USA)
Fatigue in Functional Motor Disorders.

J. Gelauff, E. Kingma, J. Stone, J. Rosmalen, M. Tijssen (Groningen, Netherlands)
FDG PET studies in the differential diagnose of atypical parkinsonism and dementia syndromes.

M.C. Peralta, M. Tourreilles, D. Menna, P. Perez Leguizamon, F. Taragano, M. Bastianello (Buenos Aires, Argentina)
Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Alpha-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)

C. Linder, B. Mollenhauer, C. Coffey, T. Beach, T. Foroud, C. Adler, H. Riss, D. Ecklund, C. Caspell-Garcia, K. Dave, S. Deshpande, S. Lasch, V. Arnedo, L. Riley, C. Kopil, D. Jennings, L. Chahine (Philadelphia, PA, USA)
Feasibility of using a smartphone application for the objective evaluation of Parkinson disease

R. Schneider, J. Adams, M. Elson, C. Tarolli, S. Sharma, A. Glidden, T. Felong, A. Zhan, R. Korn, S. Goldenthal, D. Harris, M. Xiong, M. Little, K. Biglan, R. Dorsey (Rochester, NY, USA)
Feasibility of utilizing the NIH Toolbox in Parkinson’s disease subjects with deep brain stimulation

J. Emerson, P. Dhruva, C. McLeod, R. Moses-Kessler, L. Metman, G. Pal (Chicago, IL, USA)
Feasibility, tolerability and acceptance of a psychosocial intervention for people with Parkinsonian dementia: The INVEST trial.

S. McCormick, K. McDonald, S. Vatter, V. Orgeta, E. Poliakoff, S. Smith, M. Silverdale, B. Fu, I. Leroi (Manchester, United Kingdom)
Feedback Controlled DBS in Parkinson’s Disease using Electrocorticography

N. Swann, C. de Hemptinne, A. Miller, W. Chen, I. Tamir, R Gilron, J. Ostrem, P. Starr (San Francisco, CA, USA)
Female reproductive factors and clinical features of PD

H. Liu, R. Ou, Y. Hou, Q. Wei, W. Song, B. Cao, B. Zhao, H. Shang (Chengdu, China)
Fentanyl Induced Chorea: A Case Report

M. Gallagher, A. Colcher, A. McGarry (Camden, NJ, USA)
Fibroblasts Implanted in Internal Pallidum of Parkinsonian Macaques Exert L-Dopa-Sparing Activity

E. Bezard, J. Finberg, W.K. Ko, Q. Li, B. Dehay, E. Pioli, Y. Yair (Bordeaux, France)
Final validation of an electronic diary for motor fluctuations and dyskinesias evaluation in PD patients: Comparison with paperback diary.

C. Terroba, A. Medina, F. Nanni, V. Bruno, D. Cerquetti, M. Rossi, M. Merello (Buenos Aires, Argentina)
Firing rate and proportion of subthalamic oscillatory neurons increase associated with more advanced Parkinson’s Disease

P. Zhuang, M. Hallett, Y. Wen, Y. Zhang, J. Li, Y. Li (Beijing, China)
First experience with 59 directional leads in deep brain stimulation

R. Nickl, P. Fricke, F. Steigerwald, J. Volkmann, C. Matthies (Würzburg, Germany)
First Report of Clinical Outcomes Resulting from Use of Directional Deep Brain Stimulation in Parkinson’s Disease and Essential Tremor

H. Braass, L. Venkatesan, C.-u. Choe, U. Hidding, B. Schönwald, C. Wargel, C. Buhmann, A. Gulberti, C. Moll, J. Köppen, C. Gerloff, W. Hamel, M. Pötter-Nerger (Hamburg, Germany)
First Reported Case of Parkinsonism in a Patient with Argininosuccinate Lyase Deficiency

K. Woodward, D. Bhatti, E. Rush (Omaha, NE, USA)
Five year longitudinal change in the MDS-UPDRS scores in early Parkinson’s disease participants: Results from the PPMI Study

T. Simuni, C. Caspell-Garcia, N. Seedorff, C. Coffey, S. Lasch, B. Mollenhauer, C. Tanner, K. Kieburtz, K. Marek (Chicago, IL, USA)
Fluency boost from walking in Parkinson’s disease

O. Barthelemy, R. Salazar, S. Neargarder, J. DeGutis, T. Ellis, A. Cronin-Golomb (Boston, MA, USA)
Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression

E. Dalle, D. William, M. Musa (Durban, South Africa)
Focal dystonia as an early symptom of CACNA1A mutation: case report and literature review.

Y. Gu, K. Kumar, C. Sue (Sydney, Australia)
Focused neuromodulation by short pulse width improves gait ataxia in thalamic DBS

M. Reich, N. Pozzi, G. Brandt, A. Leporini, C. Palmisano, R. Lehrke, J. Volkmann, I. Isaias (Würzburg, Germany)
Focused ultrasoud ventro-oral thalamotomy for musician’s dystonia

S. Horisawa, T. Yamaguchi, K. Abe, T. Taira (shinjyuku, Japan)
Focused ultrasound subthalamotomy for Parkinson’s disease: A pilot study

R. Martinez-Fernandez, R. Rodriguez-Rojas, M. del Álamo, F. Hernandez, J.A. Pineda-Pardo, M. di Leone, F. Alonso, I. Obeso, C. Gasca-Salas, E. de Luis, L. Vela, J.A. Obeso (Mostoles, Spain)
Focused ultrasound subthalatomy restores intracortical inhibition in PD

M. Dileone, R. Martinez-Fernandez, M. Del Alamo, R. Rodriguez, J. Pineda-Pardo, F. Hernandez-Fernandez, J. Obeso, G. Foffani (Mostoles, Spain)
Forehead Tremor: a clinical presentation of ocular Myasthenia Gravis?

G. Sciacca, E. Reggio, G. Donzuso, A. Nicoletti, M. Zappia (Catania, Italy)
Four year outcomes of a prospective, multi-center trial evaluating Deep Brain Stimulation with a new multiple-source, constant-current rechargeable system in Parkinson’s disease

L. Timmermann, R. Jain, N. Van Dyck, L. Chen, T. Brücke, F. Seijo, E. San Martin, V. Visser-Vandewalle, M. Barbe, S. Gill, A. Whone, M. Porta, D. Servello, F. Alesch (Cologne, Germany)
Fragile X Gray Zone Alleles are associated with Higher Global Motor Function in an Elderly Community Population

D. Hall, A. Ali, D. Bennett, B. Ouyang, A. Buchman, L. Zhou, E. Berry-Kravis (Chicago, IL, USA)
Freezing of gait in Parkinson’s disease consists of unique pressure-based gait phase transitions

L. Luo, D. Zanotto, F. Maget, B. Xu, S. Agrawal, P. Mazzoni (New York, NY, USA)
Freezing of gait in Parkinson’s disease: Clinical features and possible predictors

S. Prasad, A. Lenka, N. Kamble, R. Yadav, P. Pal (Bangalore, India)
Freezing of gait is an early clinical feature of progressive supranuclear palsy

Y. Osaki, Y. Morita, Y. Miyamoto, T. Furushima, K. Furuta, H. Furuya (Nankoku, Japan)
From local partnership to national network: the growth of a medically connected, community based program model for Parkinson’s wellness

A. Lemen, P. Schmidt, PhD, R. Hagestuen, RN, V. Edelson, C. Kohles, M. Donovan, T. Elkins, M. Sweeney, LMSW, A. DiRocco, MD (New York, NY, USA)
Fulfilment of Movement Disorder Society clinical diagnostic criteria for Parkinson’s disease in a large cohort study of recent onset cases.

N. Malek, M. Lawton, K. Grosset, N. Bajaj, R. Barker, Y. Ben-Shlomo, D. Burn, T. Foltynie, J. Hardy, H. Morris, N. Williams, N. Wood, D. Grosset (Ipswich, United Kingdom)
Full sequencing and GWAS markers analysis of SNCA in RBD and progression to synucleinopathies.

Z. Gan-Or, J. Ruskey, I. Arnulf, Y. Dauvilliers, B. Hogl, A. Stefani, C. Charley Monaca, P. Dion, A. Desautels, J.-F. Gagnon, N. Dupre, R. Postuma, J. Montplaisir, G. Rouleau (Montreal, QC, Canada)
Functional Connectivity Differences Across Parkinson Disease Subtypes

M. Campbell, C. Gratton, J. Koller, W. Shannon, C. Lessov-Schlaggar, S. Petersen, J. Perlmutter (St. Louis, MO, USA)
Functional lesional neurosurgery for tremor – a systematic review and meta-analysis

S. Schreglmann, J. Krauss, J. Chang, K. Bhatia, G. Kägi (London, United Kingdom)
Functional MAOB gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson’s disease

M. Löhle, G. Mangone, M. Wolz, B. Beuthien-Baumann, L. Oehme, J. Hoff, J. Kotzerke, H. Reichmann, J.-C. Corvol, A. Storch (Rostock, Germany)
Functional role of the cerebellum in Parkinson’s disease : a PET-Study

A. Riou, F. Le Jeune, J.-F. Houvenaghel, S. Drapier, M. Vérin, G. Robert (RENNES, France)
Fundamental limit of the alpha-synuclein immunohistochemistry using the endoscopic biopsy from the gastrointestinal tract as a biomarker for Parkinson disease: a case-control study

C.W. Shin, S.-H. Park, J.Y. Yun, J.H. Shin, H.-K. Yang, H.-J. Lee, S.-H. Kong, Y.J. Jung, G. Shen, H. Kim (Seoul, Republic of Korea)
FXTAS, PD, and ET subjects demonstrate distinct gait, balance and tremor deficits under normal, environmentally challenging, and dual-task conditions

E. Robertson, D. Hall, A. McAsey, M. Swanson, A. Bery, C. Huml, E. Berry-Kravis, J. O'Keefe (Chicago, IL, USA)